Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Once-Daily Application of Topical VDA-1102 Ointment for 28 Days in Subjects With Actinic Keratosis

Trial Profile

Randomized, Double-Blind, Placebo-Controlled, Parallel-Cohort Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Once-Daily Application of Topical VDA-1102 Ointment for 28 Days in Subjects With Actinic Keratosis

Completed
Phase of Trial: Phase II

Latest Information Update: 11 May 2017

At a glance

  • Drugs VDA 1102 (Primary)
  • Indications Actinic keratosis
  • Focus Therapeutic Use
  • Sponsors VidacPharma
  • Most Recent Events

    • 08 May 2017 Status changed from recruiting to completed.
    • 20 Oct 2016 Status changed from not yet recruiting to recruiting.
    • 29 Jun 2016 Status changed from planning to not yet recruiting, according to a Vidac Pharma media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top